COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes

Detalles Bibliográficos
Autores principales: Lin, Chung M A, Bennett, Josh, Rajagopala, Lavanya, Hunter, Ewan, Lorenzi, Alice R, Griffiths, Bridget, Baker, Kenneth F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234184/
https://www.ncbi.nlm.nih.gov/pubmed/36534829
http://dx.doi.org/10.1093/rheumatology/keac705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234184/
https://www.ncbi.nlm.nih.gov/pubmed/36534829
http://dx.doi.org/10.1093/rheumatology/keac705

Ejemplares similares